Log in to search using one of your social media accounts:

 

Can AI predict treatment response in bipolar patients?

Can the same type of artificial intelligence (AI) technology used in fighter...Read more on AuntMinnie.comRelated Reading: SIIM: AI poised to enhance all aspects of radiology Can machine learning and MRI diagnose depression? MRI shows promise in diagnosing CTE in living patients MRI identifies brain abnormalities in schizophrenic patients MRI links bipolar disease to cerebellum changes
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Most people understand that the role of psychiatric medications is to help alleviate the symptoms associated with different types of mental disorders, such as depression, bipolar disorder, ADHD, schizophrenia, anxiety, and more. Psychiatric medications are an important part of a comprehensive treatment plan for effectively treating people who have a mental health concern or mental illness. It’s good to know what drugs are being most-often prescribed for mental disorders in the U.S. These are the top 25 psychiatric medications by number of U.S. prescriptions dispensed in 2016, according to QuintilesIMS, a global infor...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: General Medications Psychiatry Treatment medications for mental illness Psychiatric Drugs Psychiatric Medications psychiatric meds top psychiatric medications Source Type: blogs
CONCLUSION: These findings demonstrate the impact of symptomatic remission and resilience on HRQOL of both patients suffering from schizophrenia and BD-I and indicate that these factors are especially relevant for HRQOL of patients with BD-I. PMID: 28992535 [PubMed - as supplied by publisher]
Source: Journal of the Association of European Psychiatrists - Category: Psychiatry Tags: Eur Psychiatry Source Type: research
Publication date: Available online 7 October 2017 Source:Progress in Neuro-Psychopharmacology and Biological Psychiatry Author(s): Ellen S. Ovenden, Nathaniel W. McGregor, Robin A. Emsley, Louise Warnich Antipsychotic response in schizophrenia is a complex, multifactorial trait influenced by pharmacogenetic factors. With genetic studies thus far providing little biological insight or clinical utility, the field of pharmacoepigenomics has emerged to tackle the so-called “missing heritability” of drug response in disease. Research on psychiatric disorders has only recently started to assess the link between epig...
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
Publication date: Available online 3 October 2017 Source:Neuroscience & Biobehavioral Reviews Author(s): Jairo V. Pinto, Thiago C. Moulin, Olavo B. Amaral The search for biomarkers has been a leading endeavor in biological psychiatry. To analyze its evolution over the years, we performed a systematic review to evaluate (a) the most studied peripheral molecular markers in major psychiatric disorders, (b) the main features of studies proposing them as biomarkers and (c) whether their patterns of variation are similar across disorders. Of the six molecules most commonly studied as plasmatic markers of schizophrenia, majo...
Source: Neuroscience and Biobehavioral Reviews - Category: Neuroscience Source Type: research
Conclusions Urgent research questions to further clarify the underlying pathophysiological and structural alterations are further outlined to bring this promising technique to the clinic. PMID: 28971725 [PubMed - as supplied by publisher]
Source: The World Journal of Biological Psychiatry - Category: Psychiatry Authors: Tags: World J Biol Psychiatry Source Type: research
AbstractPurpose of the ReviewNeurovascular dysfunction and the role of vascular endothelial growth factor (VEGF) have been explored in neurodevelopmental disorders including schizophrenia, bipolar disorder, major depressive and mood disorders, and autism. These disorders are correlated with hypoxia-ischemia insults during early life and are strongly associated with cognitive dysfunction. This review focuses on the hypoxia-regulated protein, VEGF, to discuss its crucial roles in brain development and function. These data implicate that alterations to VEGF signaling during early life can impair neural development, underlying...
Source: Current Behavioral Neuroscience Reports - Category: Neuroscience Source Type: research
People have said this to me many times over the years. Here’s another Wheat Belly Basics conversation for newcomers or a refresher for the seasoned Wheat Belly follower. One of the reason that wheat and related grains are such effective causes of weight gain is that they contain a protein, gliadin, that, upon digestion, yields opioid peptides that bind to the opiate receptors of the human brain. These opioid peptides are responsible for generating addictive relationships with food, as well as behavioral and emotional effects. Stop eating grains and an opiate withdrawal syndrome ensues: nausea, headache, fatigue, depr...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Wheat Belly Lifestyle addiction appetite stimulant binge eating bulimia Detox eating disorders gluten gluten-free grain-free grains health opiates opioids Weight Loss wellness withdrawal Source Type: blogs
The usefulness of medical marijuana for the treatment of mental illness and disorders such as depression, bipolar disorder, anxiety, and schizophrenia is an open question today. There have been only a few really good studies on this issue, and their findings are decidedly mixed. So let’s dive into the question and see if medical marijuana can help the symptoms of mental illness, or is it more likely to cause harm? The reason this is a very complex issue is because, unlike medical marijuana for chronic, debilitating pain, there’s a lot of additional factors that must be taken into account when studying mental i...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Alternative and Nutritional Supplements Disorders General Research Treatment anxiety Bipolar Disorder Cannabis Depression Medical Marijuana Source Type: blogs
Long-term treatment with asenapine, an atypical antipsychotic approved for treatment of bipolar mania and schizophrenia, was more effective than placebo in preventing recurrence of any mood events in adults with bipolar I disorder, according to areport inAJP in Advance.Patients with bipolar I disorder are at high risk for recurrences and relapses, noted Armin Szegedi, M.D., Ph.D., of Allergan Pharmaceuticals and colleagues. “Ideally, a compound would control symptoms of both polarities, both acutely and in the long term; however, few treatments have demonstrated this profile,” the authors wrote. For the st...
Source: Psychiatr News - Category: Psychiatry Tags: ajp in advance Armin Szegedi asenapine Bipolar I mood recurrence prevention Terence Ketter Source Type: research
Publication date: Available online 28 September 2017 Source:Aggression and Violent Behavior Author(s): Valeria Abreu Minero, Edward Barker, Rachael Bedford There is limited research that has examined offense characteristics in homicides committed by individuals with mental illness and with differing psychiatric diagnoses. The aim of this systematic review is to synthesize previous findings of studies analyzing homicide behavior by mentally ill individuals, and reporting any associations between mental illness and method of homicide. We searched four databases (MedLine, PsychINFO, Web of Science and Embase), and identified...
Source: Aggression and Violent Behavior - Category: Psychiatry & Psychology Source Type: research
More News: Bipolar | Brain | Cerebellum | Depression | Learning | Mania | Neurology | Radiology | Schizophrenia | Universities & Medical Training